Leslie G. Cleland

发表

Treatment‐induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis

L. McWilliams, C. Hall, A. Lee, 2009, Internal medicine journal (Print).

Cyclooxygenase inhibitors: any reservations?

L. Cleland, M. James, P. S. Penglis, 2001, Internal medicine journal.

Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial

L. March, G. Jones, C. Hill, 2016, Osteoporosis International.

Epidemiology of biopsy‐proven giant cell arteritis in South Australia

T. Dodd, E. Dunstan, Peter J. Roberts‐Thomson, 2014, Internal medicine journal.

Rheumatoid arthritis: are pets implicated in its etiology?

L. Cleland, C. Bond, Leslie G. Cleland, 1996, Seminars in arthritis and rheumatism.

Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes.

W. H. Betts, G. Nuki, N. Hurst, 1986, Biochemical pharmacology.

The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity

M. Wiese, R. Upton, L. Cleland, 2014, Journal of clinical pharmacy and therapeutics.

Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial

S. Proudman, L. Cleland, M. James, 2014 .

Effects of tumor necrosis factor-alpha, interleukin 1beta, and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice.

G. Mayrhofer, L. Cleland, S. Proudman, 1999, The Journal of rheumatology.

Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis.

L. Cleland, M. James, S. Proudman, 2003, Prostaglandins, leukotrienes, and essential fatty acids.